Challenges in pathologic staging of renal cell carcinoma: an interobserver variability study of urologic pathologists
Sean R. Williamson(Cleveland Clinic), Kiril Trpkov(University of Calgary), Steven Fleming(The University of Sydney), Brett Delahunt(Malaghan Institute of Medical Research), H. Moch, Michelle S. Hirsch(Perinatal Institute), Satish K. Tickoo(Unknown), Jordi Mas López, Christopher G. Przybycin(Cleveland Clinic), Hes O, Guido Martignoni(University of Verona), Priya Rao(The University of Texas MD Anderson Cancer Center), Rohit Mehra(University of Michigan–Ann Arbor), Jonathan I. Epstein(Johns Hopkins University), Milon Amin, J. N. Eble, Lin Cheng(University of Colorado Denver), Y B Chen, Maria M. Picken(Loyola University Medical Center), Nilesh Gupta(Henry Ford Health System), Mingxi Zhou(ShanghaiTech University), Naoto Kuroda, John R. Srigley(University of Toronto), Lakshmi P. Kunju(University of Michigan), Reuter, David Grignon, Fiona Maclean(VA Palo Alto Health Care System), Pheroze Tamboli, Maria Tretiakova(University of Washington)
Unknown
January 1, 2018
Cited by 1
Related Papers
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
The Banff 97 working classification of renal allograft pathology
|Kidney International|1999|3.1k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
The molecular portraits of breast tumors are conserved across microarray platforms
|BMC Genomics|2006|1.5k
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
|Nature Genetics|2013|1.2k